Longitudinal Prospective Study of Neurocognitive Outcomes and Multimodal Quantitative Neuroimaging Outcomes in Primary Brain Tumor Patients Receiving Brain Radiotherapy

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

In this proposal, the investigators introduce a novel, translational study to prospectively examine primary brain tumor patients undergoing fractionated radiation therapy to the brain. Quantitative neuroimaging, radiation dose information, and directed neurocognitive testing will be acquired through this study to improve understanding of cognitive changes associated with radiation dosage to non-targeted tissue, and will provide the basis for evidence-based cognitive- sparing brain radiotherapy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:

• Patients 18 years or older

• Karnofsky performance status (KPS) ≥70

• Life expectancy of ≥1 year

• Primary brain tumor patients who will receive fractionated partial brain RT

• Able to complete neurocognitive assessments

Locations
United States
California
Moores Cancer Center
RECRUITING
San Diego
Contact Information
Primary
Sheila Medina
s4medina@health.ucsd.edu
858-822-6575
Backup
Jona Hattangadi-Gluth, MD
Time Frame
Start Date: 2015-01
Estimated Completion Date: 2026-12
Participants
Target number of participants: 250
Treatments
Primary brain tumour patients receiving RT
Primary brain tumor patients are screened at time of consultation for this observational study, and the study population is diverse across sex/gender, and racial/ethnic groups.
Sponsors
Leads: Jona Hattangadi-Gluth

This content was sourced from clinicaltrials.gov